SCHEDULE: Fivespan Partners Takes Stake in Stride, Inc.

Fivespan Partners, LP, along with affiliated entities and Dylan G. Haggart, has disclosed a beneficial ownership stake of 5.3% in Stride, Inc., following a cooperation agreement that includes board representation.

Summary

• Fivespan Partners, LP, Fivespan Partners GP, LLC, and Dylan G. Haggart (collectively, the 'Reporting Persons') have filed a Schedule 13D, disclosing beneficial ownership of 2,236,033 shares of Stride, Inc. Common Stock, representing 5.3% of the outstanding shares.
• The acquisition was based on the belief that Stride's securities were undervalued.
• A Cooperation Agreement was entered into on October 8, 2026, between Stride, Inc. and the Reporting Persons.
• Under the agreement, Dylan G. Haggart was appointed as an independent director to Stride's Board, effective October 22, 2026, and nominated for election at the 2026 annual meeting.
• Dr. Steven Guttentag was appointed as a non-voting Board observer on October 8, 2026, and will join the Board and its Academic and Nominating and Corporate Governance Committees after the 2026 annual meeting.
• The Reporting Persons agreed to customary standstill obligations until 30 days before the 2027 nomination notice deadline, with an aggregate beneficial ownership cap of 7.5% and an aggregate economic exposure cap of 12.5%.
• Stride, Inc. agreed to reimburse the Investor Group for certain expenses related to the Cooperation Agreement.
• A Capital Allocation Committee has been formed, co-chaired by Mr. Haggart and Brian Shepherd, to advise the Board on capital structure and allocation strategy.
• Mr. Haggart also serves on the Compensation Committee.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this filing as moderately positive, indicating a strategic shift and increased engagement from a significant investor, which could lead to improved corporate governance and capital allocation.

Positives

• Significant investor (Fivespan Partners) has taken a substantial stake (5.3%) in Stride, Inc., indicating confidence in the company's value.
• A Cooperation Agreement has been established, leading to board representation for Dylan G. Haggart and a board observer role for Dr. Steven Guttentag, enhancing corporate governance.
• Formation of a Capital Allocation Committee, co-chaired by Mr. Haggart, suggests a focus on optimizing the company's financial strategy and shareholder returns.
• Mr. Haggart's appointment to the Compensation Committee further integrates the investor's perspective into key decision-making areas.
• Stride, Inc. has agreed to reimburse the investor group for certain expenses, demonstrating a willingness to collaborate.

Negatives

• The filing indicates that the Reporting Persons acquired the securities based on a belief that they were undervalued, which could imply a prior period of underperformance or mispricing by the market.
• The Cooperation Agreement includes standstill obligations, which may limit the investor group's ability to take certain actions for a defined period.

Risks

• Potential for disagreements between the new board members and existing management or board members regarding strategic direction or capital allocation.
• The standstill obligations and ownership caps could limit future flexibility for both the investor group and the company.
• Future discussions with directors, officers, and other stakeholders may lead to further strategic changes or potential activism.

Future Outlook

The Reporting Persons expect to continue engaging in discussions with Stride's management and board regarding various aspects of the business, including operations, capital allocation, and strategy. They may take future actions such as purchasing additional securities, selling existing holdings, or engaging in hedging transactions, depending on various factors.

Management Comments

• The Reporting Persons acquired the securities of the Issuer reported herein based on their belief that the securities were undervalued and represented an attractive investment opportunity.
• The Reporting Persons have, from time to time, engaged in, and, subject to the terms of the Cooperation Agreement, expect to continue to engage in, discussions with directors and officers of the Issuer in connection with the Reporting Persons' investment in the Issuer.
• Such discussions may include, without limitation, a range of issues, including those relating to the business of the Issuer, management, board composition, investor communications, operations, assets, capital allocation, dividend policy, financial condition, mergers and acquisitions strategy, overall business strategy, executive compensation and corporate governance.

Industry Context

StockSavvy.ai notes that activist investor engagement and cooperation agreements leading to board seats are common strategies in the current market environment, particularly when investors perceive undervaluation or opportunities for strategic improvement in a company's capital allocation or governance.

Management Changes

Corporate Governance

Related Party Transactions

• Stride, Inc. agreed to reimburse the Investor Group (Fivespan Partners, LP, Fivespan Partners GP, LLC, Dylan G. Haggart) for certain expenses incurred in connection with the Cooperation Agreement, subject to a cap.

Stakeholder Impact

• Shareholders: Potential for improved corporate governance and capital allocation strategies, which could lead to increased shareholder value. However, the standstill agreement may limit immediate activist actions.
• Board of Directors: Increased oversight and integration of investor perspectives through new board members and committee participation.
• Management: May face increased scrutiny and need to align strategic initiatives with the new board members' perspectives, particularly regarding capital allocation.

Next Steps

• Mr. Haggart will serve on the Board of Directors with a term expiring at the Issuer's 2027 annual meeting.
• Dr. Guttentag will join the Board and its Academic and Nominating and Corporate Governance Committees following the 2026 annual meeting, with a term expiring at the 2027 annual meeting.
• The Reporting Persons may continue to engage in discussions with Stride's management and board regarding business strategy, capital allocation, and other matters.
• The Reporting Persons may take future actions regarding their investment, including purchasing or selling additional securities or engaging in hedging transactions.

Key Dates

Recommendation

The filing indicates a positive development with increased investor engagement and board representation, suggesting potential for strategic improvements. However, the exact impact on future performance is not yet clear, and the investor group's future actions are subject to the terms of the cooperation agreement. Therefore, a 'hold' recommendation is appropriate pending further developments and clarity on the execution of the new strategic direction.

Keywords

Schedule 13D, Fivespan Partners, Stride Inc., Beneficial Ownership, Cooperation Agreement, Board of Directors, Capital Allocation, Investment Management